Bioextrax AB (publ) (STO:BIOEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.430
-0.030 (-1.22%)
At close: Feb 5, 2026

Bioextrax AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7.9217.2713.427.538.982.05
Cash & Short-Term Investments
7.9217.2713.427.538.982.05
Cash Growth
-12.23%28.87%-51.33%206.69%337.54%250.73%
Accounts Receivable
0.19--0.030.12-
Other Receivables
0.240.730.711.270.790.17
Receivables
0.440.730.711.30.910.17
Prepaid Expenses
1.60.290.290.340.220.22
Other Current Assets
-0.910.361.231.31-
Total Current Assets
9.9519.214.7630.411.422.44
Property, Plant & Equipment
6.126.827.767.491.220.6
Other Long-Term Assets
-2.98-0.03--
Total Assets
16.082922.5237.9212.643.03
Accounts Payable
0.741.531.333.562.220.15
Accrued Expenses
1.260.840.440.981.040.65
Current Income Taxes Payable
-0.10.140.130.060.03
Current Unearned Revenue
---0.590.891.41-
Other Current Liabilities
0.430.470.670.60.410.55
Total Current Liabilities
2.432.941.986.155.141.38
Total Liabilities
2.432.941.986.155.141.38
Common Stock
2.021.971.471.280.740.64
Additional Paid-In Capital
-22.329.8641.7315.965.78
Retained Earnings
11.641.739.21-11.24-9.2-4.76
Comprehensive Income & Other
-00.05--0-
Shareholders' Equity
13.6526.0620.5431.777.51.65
Total Liabilities & Equity
16.082922.5237.9212.643.03
Net Cash (Debt)
7.9217.2713.427.538.982.05
Net Cash Growth
-12.23%28.87%-51.33%206.69%337.54%250.73%
Net Cash Per Share
0.200.520.511.630.670.17
Filing Date Shares Outstanding
40.0339.1229.2325.4614.7512.66
Total Common Shares Outstanding
40.0339.1229.2325.4614.7512.66
Working Capital
7.5316.2612.7824.256.281.06
Book Value Per Share
0.340.670.701.250.510.13
Tangible Book Value
13.6526.0620.5431.777.51.65
Tangible Book Value Per Share
0.340.670.701.250.510.13
Machinery
-9.999.778.641.90.92
Source: S&P Global Market Intelligence. Standard template. Financial Sources.